Skip to main content

Incyte to Present at Upcoming Investor Conferences

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of November:

  • Guggenheim Annual Healthcare Innovation Conference on Monday, November 10, 2025 at 10:00 am (EST)
  • Jefferies Global Healthcare Conference (London) on Tuesday, November 18, 2025 at 11:00 am (GMT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  258.87
+1.12 (0.43%)
AAPL  354.65
+1.88 (0.53%)
AMD  504.52
+0.24 (0.05%)
BAC  49.98
-0.09 (-0.19%)
GOOG  280.22
-1.04 (-0.37%)
META  623.52
-2.89 (-0.46%)
MSFT  511.00
-6.99 (-1.35%)
NVDA  155.28
-0.86 (-0.55%)
ORCL  117.63
-1.46 (-1.23%)
TSLA  381.38
+1.64 (0.43%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.